Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
0.55 Down 0.00(0.54%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:0.55
Open:0.55
Bid:0.54 x 500
Ask:0.80 x 200
1y Target Est:4.56
Beta:5.21
Next Earnings Date:N/A
Day's Range:0.53 - 0.57
52wk Range:0.36 - 2.52
Volume:746,645
Avg Vol (3m):3,150,090
Market Cap:82.64M
P/E (ttm):N/A
EPS (ttm):-0.57
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTXDown 0.54%82.64M
ASTM 0.00%N/A
BAXDown 1.44%20.82B
OSIRDown 1.48%662.70M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.29
Quarterly EPS Est (Jun-15) :-0.03
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback